1.A Case of the Hepatocellular Carcinoma during the Pregnancy and Metastasis to the Left Atrium.
Soon Woo NAM ; Jong Tae BAEK ; Sang Bum KANG ; Dong Soo LEE ; Jin Il KIM ; Se Hyun CHO ; Soo Heon PARK ; Joon Yeol HAN ; Byung Min AHN ; Jae Kwang KIM ; Kyu Won CHUNG
The Korean Journal of Hepatology 2005;11(4):381-385
A 28-year-old female with a pregnant state of 29th gestational week was admitted because of nausea and vomiting. MRI showed a huge hepatocellular carcinoma. At the 36th gestational week, a normal delivery was done. Surgery of hepatocellular carcinoma was done at 20 days after delivery. After 22 months from the operation, pulmonary metastasis was found and resection of lung mass was done. About 3 years after resection, a low attenuating nodule was detected in the left atrial chamber of heart. We report a case of hepatocellular carcinoma with metastatic lesions to lung and heart in a pregnant woman.
Adult
;
Carcinoma, Hepatocellular/diagnosis/*secondary/surgery
;
Female
;
Heart Atria
;
Heart Neoplasms/diagnosis/*secondary
;
Humans
;
Infant, Newborn
;
Liver Neoplasms/diagnosis/*pathology/surgery
;
Lung Neoplasms/diagnosis/secondary
;
Pregnancy
;
*Pregnancy Complications, Neoplastic/diagnosis
2.Colon hepatoid adenocarcinoma with live metastasis.
Jie ZHANG ; Xiao-jing LI ; Hao-hua TENG
Chinese Journal of Pathology 2005;34(4):249-250
Adenocarcinoma
;
metabolism
;
secondary
;
surgery
;
Carcinoembryonic Antigen
;
metabolism
;
Carcinoma, Hepatocellular
;
metabolism
;
secondary
;
surgery
;
Colectomy
;
Colonic Neoplasms
;
metabolism
;
pathology
;
surgery
;
Diagnosis, Differential
;
Humans
;
Keratin-18
;
metabolism
;
Liver Neoplasms
;
metabolism
;
secondary
;
surgery
;
Male
;
Middle Aged
;
alpha-Fetoproteins
;
metabolism
3.Adrenal Metastasis from Hepatocellular Carcinoma without Intrahepatic Recurrence after Hepatic Resection.
Sung Min AHN ; Min Young JUNG ; Hyeok Soo CHOI ; Bo Youn CHOI ; Seung In SEO ; Du Jin KIM ; Seung Jin CHO ; Hyoung Su KIM
The Korean Journal of Gastroenterology 2012;59(4):308-312
Although the adrenal gland is a common site of metastasis from hepatocellular carcinoma (HCC), adrenal metastases are rarely seen in clinical practice because of its lower metastatic potential compared to the other malignancies. Adrenal metastases usually were detected at the time of diagnosis of primary HCC or simultaneously with intrahepatic recurrence after curative management of HCC. It is very rare that only metastatic HCC is detected without evidence of intrahepatic recurrence. Hereby, we report two cases of adrenal metastasis from HCC without intrahepatic recurrence after hepatic resection.
Adrenal Gland Neoplasms/*diagnosis/radionuclide imaging/secondary
;
Aged, 80 and over
;
Carcinoma, Hepatocellular/*pathology/surgery
;
Humans
;
Liver Neoplasms/*pathology/surgery
;
Male
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
4.Clinical Outcome of Pulmonary Resections in Patients with Pulmonary Metastasis of Hepatocellular Carcinoma.
Kyung Kyu KIM ; Ja Kyung KIM ; Do Young KIM ; Sang Hoon AHN ; Chae Yoon CHON ; Young Myoung MOON ; Kyung Young CHUNG ; Kwang Hyub HAN
The Korean Journal of Hepatology 2005;11(4):350-358
BACKGROUND/AIMS: Although the lung is the most common site of extrahepatic spread from hepatocellular carcinoma (HCC), the role of surgery for pulmonary metastasis remains unclear. The aim of this study was to evaluate the efficacy of pulmonary resection in patients with pulmonary metastasis from HCC. METHODS: Between July 2000 and July 2004, a total of 6 patients with pulmonary metastasis from HCC underwent curative pulmonary resections. The patients were divided into two groups (Surgery group and Non-surgery group) according to the primary treatment modality of HCC. Medical records, imaging studies, and pathologic reports of the surgical specimens were reviewed. RESULTS: Three patients in the surgery group underwent pulmonary resections for a solitary metastasis after hepatectomy for HCC, and they are all still alive. One of the 3 patients developed a tumor recurrence in the chest wall after pulmonary resection. The survival time after diagnosis of HCC were 79, 122, and 54 months, respectively. The survival time after pulmonary metastatectomy were 49, 39, and 20 months in the three patients. Another 3 patients in the non-surgery group, received a pulmonary metastatectomy; they had either a complete response HCC or partial radiologic response. These 3 patients developed recurrent disease in the liver. One of 3 patients died. The survival time after diagnosis of HCC were 153, 83, 12 months. The survival time after pulmonary metastatectomy were 51, 4, 2 months. CONCLUSIONS: The surgical resections of a solitary pulmonary metastasis from HCC in highly selected patients might be an effective treatment modalities for prolonged survival.
Adult
;
Carcinoma, Hepatocellular/diagnosis/mortality/*secondary/*surgery
;
Humans
;
Liver Neoplasms/*pathology
;
Lung Neoplasms/diagnosis/mortality/*secondary/*surgery
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local
;
*Pneumonectomy/mortality
;
Survival Rate
;
Treatment Outcome
5.Sarcomatoid hepatocellular carcinoma.
The Korean Journal of Hepatology 2010;16(1):89-94
No abstract available.
Carcinoma, Hepatocellular/*pathology/secondary/surgery
;
Diagnosis, Differential
;
Hepatitis B, Chronic/diagnosis
;
Humans
;
Liver Neoplasms/diagnosis/*pathology/surgery
;
Male
;
Middle Aged
;
Sarcoma/diagnosis/*pathology/surgery
;
Tomography, X-Ray Computed
;
Vimentin/metabolism
6.Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma.
Jin WANG ; Bing-jun HE ; Zai-bo JIANG ; Ya-qin ZHANG ; Hong SHAN ; Ru XIAO ; Jian-sheng ZHANG ; Lin LUO ; Si-chi KUANG ; Gui-hua CHEN ; Yang YANG
Chinese Journal of Oncology 2009;31(9):691-696
OBJECTIVETo investigate the manifestation and diagnostic value of multislice spiral CT (MSCT) and MRI imaging in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma (HCC).
METHODSThe clinical data of 161 consecutive HCC patients who underwent orthotopic liver transplantation were retrospectively reviewed. Twenty-nine HCC patients were classified by pTNM according to the "Pittsburgh criteria". MSCT and MRI findings of tumor recurrence after liver transplantation were evaluated retrospectively in 29 stage II-IVb HCC patients. The recurrence site and relapse interval between liver transplantation and recurrence were analyzed.
RESULTSLung tumor recurrence were found in 21 cases, presented as cotton-like lesions in a diameter of 2 - 3 cm, with a clear margin and homogeneous density. Pleural tumor recurrence was detected in 4 cases. Liver tumor recurrence were found in 9 cases, which can be divided into four subtypes: multinodular in 4 cases, diffuse lesion in 2 cases, huge mass in 2 cases, and uninodular in 1 case. Two cases showed tumor thrombus in the inferior vena cava and portal vein. Lymph node tumor recurrence was found in 9 cases, presented as multiple nodules at hepatic hilum, lesser peritoneal sac, posterior mediastinum, retroperitoneum, or around pancreatic head, and accompanied with merging and necrosis in one case. Bone tumor recurrence were found as osteolytic destruction in 4 cases, and accompanied with adjacent soft-tissue mass in 2 cases. The recurrence sites of the 29 cases were as following: lung (21 cases, 72.4%), liver (9 cases, 31.0%), lymph nodes (9 cases, 31.0%), bone (4 cases, 13.8%) and other sites (3 cases, 10.3%). Lung tumor recurrence was found in all the 10 stage IVb patients with tumor recurrence after liver transplantation, significantly more frequent than that in stage IVa patients (P = 0.023). After liver transplantation, all 25 patients with stage III approximately IVb HCC developed recurrence within one year, but in the 4 cases with stage II HCC at one year later (P = 0.009).
CONCLUSIONThe results of our study show that in hepatocellular carcinoma patients after liver transplantation, the lung and pleura are the most frequent site of recurrence, followed by liver, lymph node and bone as the second and third sites. The Stage IVb hepatocellular carcinoma should be regarded as a contradiction for liver transplantation due to rapid recurrence. Tumor recurrence occurs later in stage II HCC than in stage III approximately IVb patients. MSCT and MRI are of significant importance in diagnosis and formulating operation plan in HCC patients with recurrence after liver transplantation.
Adult ; Carcinoma, Hepatocellular ; diagnosis ; diagnostic imaging ; secondary ; surgery ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms ; diagnosis ; diagnostic imaging ; pathology ; surgery ; Liver Transplantation ; Lung Neoplasms ; diagnosis ; diagnostic imaging ; secondary ; Lymphatic Metastasis ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; diagnosis ; diagnostic imaging ; Neoplastic Cells, Circulating ; Pleural Neoplasms ; diagnosis ; diagnostic imaging ; secondary ; Retrospective Studies ; Tomography, Spiral Computed ; methods
7.Multiple Colonic Metastases from Hepatocellular Carcinoma.
Gwi Hong JEONG ; Byong Duk YE ; Seung Jae MYUNG
The Korean Journal of Gastroenterology 2011;58(5):288-292
No abstract available.
Carcinoma, Hepatocellular/*pathology/surgery
;
Catheter Ablation
;
Colonic Neoplasms/*diagnosis/pathology/*secondary
;
Colonoscopy
;
Humans
;
Liver Neoplasms/*pathology/surgery
;
Male
;
Middle Aged
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
;
Whole Body Imaging
8.A Case of Hepatic Metastasis of Gastric Hepatoid Adenocarcinoma Mistaken for Primary Hepatocellular Carcinoma.
Ji Yoon MOON ; Gwang Ha KIM ; Jae Hoon CHEONG ; Bong Eun LEE ; Dong Yup RYU ; Geun Am SONG
The Korean Journal of Gastroenterology 2012;60(4):262-266
Gastric hepatoid adenocarcinoma is a special type of gastric carcinoma, which produces AFP. We report a case of an metastatic gastric hepatoid adenocarcinoma mistaken for primary hepatocellular carcinoma (HCC). A 72 year-old woman was transferred to our hospital for treatment of the hepatic mass. She underwent subtotal gastrectomy for gastric cancer 2 years ago. A year ago, she was diagnosed with hepatic mass and treated with transhepatic chemoembolization under the suspicion of primary HCC in other hospital. The hepatic mass looked like primary HCC on CT, and serum AFP was elevated to 18,735 IU/mL. We did the transhepatic mass biopsy and compared it to the histology of the previous gastric cancer. The results of immunohistochemical staining between them was coincident, and so it was diagnosed as a hepatic metastasis of gastric hepatoid adenocarcinoma.
Adenocarcinoma/*diagnosis/pathology/surgery
;
Aged
;
Carcinoma, Hepatocellular/*diagnosis/therapy
;
Embolization, Therapeutic
;
Endoscopy, Gastrointestinal
;
Homeodomain Proteins/metabolism
;
Humans
;
Keratin-20/metabolism
;
Keratin-7/metabolism
;
Liver Neoplasms/diagnosis/*secondary/therapy
;
Male
;
Stomach Neoplasms/*diagnosis/pathology/surgery
;
Tomography, X-Ray Computed
;
alpha-Fetoproteins/analysis
9.A Case of Hepatic Metastasis of Gastric Hepatoid Adenocarcinoma Mistaken for Primary Hepatocellular Carcinoma.
Ji Yoon MOON ; Gwang Ha KIM ; Jae Hoon CHEONG ; Bong Eun LEE ; Dong Yup RYU ; Geun Am SONG
The Korean Journal of Gastroenterology 2012;60(4):262-266
Gastric hepatoid adenocarcinoma is a special type of gastric carcinoma, which produces AFP. We report a case of an metastatic gastric hepatoid adenocarcinoma mistaken for primary hepatocellular carcinoma (HCC). A 72 year-old woman was transferred to our hospital for treatment of the hepatic mass. She underwent subtotal gastrectomy for gastric cancer 2 years ago. A year ago, she was diagnosed with hepatic mass and treated with transhepatic chemoembolization under the suspicion of primary HCC in other hospital. The hepatic mass looked like primary HCC on CT, and serum AFP was elevated to 18,735 IU/mL. We did the transhepatic mass biopsy and compared it to the histology of the previous gastric cancer. The results of immunohistochemical staining between them was coincident, and so it was diagnosed as a hepatic metastasis of gastric hepatoid adenocarcinoma.
Adenocarcinoma/*diagnosis/pathology/surgery
;
Aged
;
Carcinoma, Hepatocellular/*diagnosis/therapy
;
Embolization, Therapeutic
;
Endoscopy, Gastrointestinal
;
Homeodomain Proteins/metabolism
;
Humans
;
Keratin-20/metabolism
;
Keratin-7/metabolism
;
Liver Neoplasms/diagnosis/*secondary/therapy
;
Male
;
Stomach Neoplasms/*diagnosis/pathology/surgery
;
Tomography, X-Ray Computed
;
alpha-Fetoproteins/analysis
10.Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Joon Seong AHN ; Ja Ryong JEON ; Hong Seok YOO ; Taek Kyu PARK ; Cheol Keun PARK ; Dong Hyun SINN ; Seung Woon PAIK
Clinical and Molecular Hepatology 2013;19(2):173-178
Hepatoid adenocarcinoma (HAC) is a rare type of extrahepatic carcinoma whose morphology is similar to that of hepatocellular carcinoma (HCC). Metachronous HCC and HAC in the same patient is extremely rare. The case of a 68-year-old man with chronic hepatitis B infection who had both HCC and HAC of the stomach is reported herein. Nine years previously this patient had been diagnosed with HCC and received a right lobectomy. HCC that recurred at the caudate lobe at 6 months after the operation was successfully treated with transarterial chemoembolization. The patient was followed up regularly thereafter without evidence of tumor recurrence for 9 years. In July 2010 his serum alpha-fetoprotein (AFP) level elevated from 6.5 ng/mL to 625.4 ng/mL, and he developed a probable single metastatic lymph node around the hepatic artery without intrahepatic lesions. Subsequent evaluation with upper endoscopy revealed a 4-cm ulcerative lesion on the antrum of the stomach. Subtotal gastrectomy was performed with lymph-node dissection. Histologic examination revealed a special type of extrahepatic AFP-producing adenocarcinoma-HAC with lymph-node metastasis-which indicates that HAC can be a cause of elevated AFP even in patients with HCC. HAC should be considered if a patient with stable HCC exhibits unusual elevation of AFP.
Adenocarcinoma/*diagnosis/drug therapy/secondary
;
Aged
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Camptothecin/analogs & derivatives/therapeutic use
;
Carcinoma, Hepatocellular/*diagnosis/drug therapy/pathology
;
Chemoembolization, Therapeutic
;
Chemotherapy, Adjuvant
;
Fluorouracil/therapeutic use
;
Gastroscopy
;
Humans
;
Leucovorin/therapeutic use
;
Liver Neoplasms/*diagnosis/drug therapy/pathology
;
Lymph Nodes/surgery
;
Lymphatic Metastasis
;
Male
;
Recurrence
;
Silicates/therapeutic use
;
Stomach Neoplasms/*diagnosis/drug therapy/secondary
;
Titanium/therapeutic use
;
Tomography, X-Ray Computed
;
alpha-Fetoproteins/*analysis